Abstract

After spinal cord injury, functions of the lower urinary tract may be disrupted. A wearable device with surface electrodes which can effectively control the bladder functions would be highly beneficial to the patients. A trans-rectal pudendal nerve stimulator may provide such a solution. However, the major limiting factor in such a stimulator is the high level of current it requires to recruit the nerve fibers. Also, the variability of the trajectory of the nerve in different individuals should be considered. Using computational models and an approximate trajectory of the nerve derived from an MRI study, it is demonstrated in this paper that it may be possible to considerably reduce the required current levels for trans-rectal stimulation of the pudendal nerve compared to the values previously reported in the literature. This was corroborated by considering an ensemble of possible and probable variations of the trajectory. The outcome of this study suggests that trans-rectal stimulation of the pudendal nerve is a plausible long term solution for treating lower urinary tract dysfunctions after spinal cord injury.

Highlights

  • T HE primary functions of the lower urinary tract (LUT) are urine storage and voiding

  • The extracellular potential is simulated in a volume conductor model and is used in computational models of neurons and their segments to model the dynamic response of nerves to extracellular potential

  • Pudendal nerve stimulation has been shown to offer the possibility of controlling bladder function after spinal cord injury (SCI)

Read more

Summary

Introduction

T HE primary functions of the lower urinary tract (LUT) are urine storage and voiding. These functions depend on the coordinated activities of the bladder muscle (detrusor) and an outlet consisting of the bladder neck and urethral musculature. This coordination is mediated by the neural signals conveyed to and from the central nervous system and the periphery of the body through peripheral nerves. Prevalent treatment and management of these conditions uses a combination of drugs to suppress NDO and intermittent catheterization for voiding. This combination will ensure that the quality of life is increased for patients

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.